| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness
|
Goffin, John R.
|
|
2016
|
101 |
C |
p. 98-103
|
artikel
|
| 2 |
Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation
|
Tanizaki, Junko
|
|
2016
|
101 |
C |
p. 11-15
|
artikel
|
| 3 |
Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer
|
Suzuki, Yuzo
|
|
2016
|
101 |
C |
p. 92-97
|
artikel
|
| 4 |
Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma
|
Song, Zhengbo
|
|
2016
|
101 |
C |
p. 16-21
|
artikel
|
| 5 |
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma
|
Lam, Sze-Kwan
|
|
2016
|
101 |
C |
p. 111-119
|
artikel
|
| 6 |
Contents
|
|
|
2016
|
101 |
C |
p. v-vi
|
artikel
|
| 7 |
Corrigendum to “In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2” [Lung Cancer 53 (3) (September 2006) 273–284]
|
Finan, Katherine M.
|
|
2016
|
101 |
C |
p. 149
|
artikel
|
| 8 |
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
|
Hendriks, Lizza E.L.
|
|
2016
|
101 |
C |
p. 68-75
|
artikel
|
| 9 |
Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methods
|
Kao, Hua-Lin
|
|
2016
|
101 |
C |
p. 40-47
|
artikel
|
| 10 |
Drug interaction between erlotinib and phenytoin for brain metastases in a patient with nonsmall cell lung cancer
|
Ohgami, Masahiro
|
|
2016
|
101 |
C |
p. 9-10
|
artikel
|
| 11 |
Editorial Board
|
|
|
2016
|
101 |
C |
p. iii
|
artikel
|
| 12 |
Erratum to “Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer” [Lung Cancer 69/2 (2010) 232–238]
|
Komiya, Kazutoshi
|
|
2016
|
101 |
C |
p. 148
|
artikel
|
| 13 |
Erratum to “Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells” [Lung Cancer 73 (3) (2011) 302–309]
|
Akca, Hakan
|
|
2016
|
101 |
C |
p. 147
|
artikel
|
| 14 |
Erratum to “Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network” [Lung Cancer, 97 (July 2016), 99–104]
|
Remon, Jordi
|
|
2016
|
101 |
C |
p. 146
|
artikel
|
| 15 |
Expression of mesothelin in thymic carcinoma and its potential therapeutic significance
|
Thomas, Anish
|
|
2016
|
101 |
C |
p. 104-110
|
artikel
|
| 16 |
Express of concern on ‘Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy’
|
Philippov, P.P.
|
|
2016
|
101 |
C |
p. 145
|
artikel
|
| 17 |
High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form
|
Copin, Marie-Christine
|
|
2016
|
101 |
C |
p. 59-67
|
artikel
|
| 18 |
Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group
|
Armato III, Samuel G.
|
|
2016
|
101 |
C |
p. 48-58
|
artikel
|
| 19 |
Limited thymectomy as a potential alternative treatment option for early-stage thymoma: A multi-institutional propensity-matched study
|
Narm, Kyoung Shik
|
|
2016
|
101 |
C |
p. 22-27
|
artikel
|
| 20 |
Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation
|
Bernhardt, Denise
|
|
2016
|
101 |
C |
p. 76-81
|
artikel
|
| 21 |
Peri- and postoperative management of stage I–III Non Small Cell Lung Cancer: Which quality of care indicators are evidence-based?
|
Numan, Rachel C.
|
|
2016
|
101 |
C |
p. 129-136
|
artikel
|
| 22 |
Pre- and postoperative care for stage I–III NSCLC: Which quality of care indicators are evidence-based?
|
Numan, Rachel C.
|
|
2016
|
101 |
C |
p. 120-128
|
artikel
|
| 23 |
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma
|
Aramini, Beatrice
|
|
2016
|
101 |
C |
p. 82-87
|
artikel
|
| 24 |
Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC
|
Bhooshan, Neha
|
|
2016
|
101 |
C |
p. 88-91
|
artikel
|
| 25 |
Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study
|
Nosaki, Kaname
|
|
2016
|
101 |
C |
p. 1-8
|
artikel
|
| 26 |
Robot-assisted surgery for lung cancer: State of the art and perspectives
|
Veronesi, Giulia
|
|
2016
|
101 |
C |
p. 28-34
|
artikel
|
| 27 |
The impact of lung cancer surgery on quality of life trajectories in patients and family caregivers
|
Kim, Jae Y.
|
|
2016
|
101 |
C |
p. 35-39
|
artikel
|
| 28 |
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients
|
Thongprasert, Sumitra
|
|
2016
|
101 |
C |
p. 137-144
|
artikel
|
Tijdschrift beschrijving